Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyan Zhou

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
European Journal of Medicinal Chemistry|February 24, 2026
Structure-activity relationship profiling of N-substituted 8-trifluoromethyl-9H-purin-6-amines as mitochondrial protonophoresEmily L Krinos, Rei J Fields, Isabella M DeLuca, et al.
The Journal of Clinical Investigation|October 26, 2023
The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomniaGarth T Whiteside, Donald J Kyle, Ram P Kapil, et al.
Arthritis Research & Therapy|November 30, 2013
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapyCheng Liao, Jonathan Hsu, Yong Kim, et al.
Cancer Research|September 19, 2015
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular CarcinomaYuan Tian, Vincent W S Wong, Grace L H Wong, et al.
Journal of Medicinal Chemistry|February 14, 2014
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitorsMatthew C Lucas, Niala Bhagirath, Eric Chiao, et al.
Journal of Medicinal Chemistry|January 29, 2013
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitorsFernando Padilla, Niala Bhagirath, Shaoqing Chen, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
European Journal of Medicinal Chemistry|February 24, 2026
Structure-activity relationship profiling of N-substituted 8-trifluoromethyl-9H-purin-6-amines as mitochondrial protonophoresEmily L Krinos, Rei J Fields, Isabella M DeLuca, et al.
The Journal of Clinical Investigation|October 26, 2023
The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomniaGarth T Whiteside, Donald J Kyle, Ram P Kapil, et al.
Arthritis Research & Therapy|November 30, 2013
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapyCheng Liao, Jonathan Hsu, Yong Kim, et al.
Cancer Research|September 19, 2015
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular CarcinomaYuan Tian, Vincent W S Wong, Grace L H Wong, et al.
Journal of Medicinal Chemistry|February 14, 2014
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitorsMatthew C Lucas, Niala Bhagirath, Eric Chiao, et al.
Journal of Medicinal Chemistry|January 29, 2013
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitorsFernando Padilla, Niala Bhagirath, Shaoqing Chen, et al.
Pageof 6